|
|
Article: BUSINESS WIRE DAILY SUMMARY - MAY 28, 2009.
- Article from:
- AsiaPulse News
- Article date:
- May 29, 2009
CopyrightCOPYRIGHT 2009 Asia Pulse Pty Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
A summary of news releases for May 28, 2009 compiled by Business Wire, the global leader in news distribution. To view any of these news releases on Business Wire's website, please go to www.businesswire.com.
1) Category Code: Pharmaceutical
PFIZER'S SUTENT IS RECOMMENDED FOR REIMBURSEMENT FOR GASTROINTESTINAL STROMAL TUMOR PATIENTS BY BRITISH HEALTH AGENCY
Pfizer Inc said today that the United Kingdom's National Institute for Health and Clinical Excellence (NICE) has issued its final appraisal document (FAD) recommending reimbursement for Sutent (sunitinib malate) as a second-line treatment for patients with advanced gastrointestinal stromal ...